Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus Non-structural protein 3 (NSP3) is a multifunctional viral protein essential for the rotavirus replication cycle. It acts as a functional surrogate for the cellular poly(A)-binding protein (PABP) by binding to the conserved 3'-terminal consensus sequence (GACC) of viral mRNAs and interacting with the eukaryotic translation initiation factor 4G (eIF4G) (Piron et al., 1998; Vende et al., 2000). By outcompeting PABP for eIF4G binding, NSP3 evicts PABP from the translation initiation complex, which leads to the shutoff of host protein synthesis and the relocalization of PABP to the nucleus (Poncet et al., 1994; Harb et al., 2008). This mechanism effectively hijacks the host's translational machinery to prioritize the synthesis of viral proteins. In addition to its role in translation, NSP3 is involved in the circularization of viral polysomes, which enhances the efficiency of viral mRNA translation (Groft & Burley, 2002). Because of its central role in viral pathogenesis and host-cell takeover, NSP3 is a primary target for antiviral development. Experimental therapeutic approaches include the use of Hsp90 inhibitors like NVP-HSP990 to block the formation of functional NSP3 dimers and siRNA-mediated knockdown to restore host protein synthesis and inhibit viral spread (Montero et al., 2006; NIH, 2025).
Inhibition of NSP3 dimerization via Hsp90 inhibition, disruption of the NSP3-eIF4G interaction, or siRNA-mediated silencing of NSP3 expression to restore host translation and reduce viral replication.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus Non-structural protein 3 (NSP3) (NSP3).